PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • This composition can be in any suitable form (depending upon the desired method of administering it to a patient).The CTLA4 proteins of the disclosure can be administered to a patient by a variety of routes such as orally, transdermally, subcutaneously, intranasally, intravenously, intramuscularly, intraocularly, topically, intrathecally and intracerebroventricularly.
http://www.w3.org/ns/prov#wasQuotedFrom
  • freepatentsonline.com